SMPD1 and melanoma: Not only does Ad5H2E-PPE1(3x)-ASMase or Ad5H2E-mVEGFR2-ASMase treatment markedly left shift the dose response for cure of radiation sensitive MCA/129 fibrosarcomas, but confers cure onto radio-incurable B16 melanomas.